Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI

NCT03367312 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT03367312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Completed
Start date
March 29, 2018
Completion date
November 1, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary vascular disease